In a double-blind investigation of the efficacy on pain following abdominal or orthopaedic surgery, meptazinol 100 mg, a new hexahydroazepine derivative, was found to be equipotent with pentazocine 60 mg and pethidine 100 mg when given i.m. Analgesia was maximal 30-60 min after injection and was still present at the end of 2 h. The duration of action of meptazinol was estimated to be 4 h. Meptazinol produced less sedation and a greater sparing of lung function tests than did pethidine and pentazocine. When meptazinol or morphine was administered for further pain relief in a single-blind manner there was no evidence of patient preference for one drug or the other.
Interest in opiate-antagonist drugs possessing analgesic properties (Lasagna and Beecher, 1954; Harris and Pierson, 1964) has grown steadily since Isbell (1956) and Fraser and Rosenberg (1964) reported that such analgesics have a low addiction potential in man. Meptazinol (m-(3-ethyl-l methylhexahydro-1 H-azepin-3-yl) phenol hydrochloride), a new hexahydroazepine derivative, is a potent analgesic in animals (Goode and White, 1971 ) and man (Oosterlinck and De Sy, 1975; Paymaster, 1976) . Given subcutaneously, it is approximately equipotent with pentazocine in the rat tail radiant heat test and the mouse acetylcholine writhing test (Goode and White, 1971) . In the anaesthetized cat, meptazinol antagonized ouabain-and adrenaline-induced arrhythmia and ventricular fibrillation caused by hypothermia (Goode and White, 1971) . In man, meptazinol in doses of 50-100 mg i.m. relieved pain following abdominal surgery without depressing respiration or the cardiovascular system; the analgesic effect was significant 30 min after injection, reached a peak after 1 h and was still present after 2 h (Paymaster, 1976) .
This double-blind investigation was undertaken to assess the analgesic effect of, and tolerance to, meptazinol compared with pentazocine and pethidine given i.m. to patients suffering pain following abdominal or orthopaedic surgery. In addition to subjective and observer assessments of pain relief, lung function tests were used in the evaluation of the analgesic effect of the drugs after abdominal surgery.
MATERIALS AND METHODS
Seventy-five patients aged 20-74 yr were studied; the NALIN J. PAYMASTER, D.A., F.F.A.R.C.S., Clatterbridge Hospital, Bebington, Wirral, and Rheumatology Unit, Leasowe Hospital, Wirral, Merseyside. majority were female. They were divided into 25 groups of three, matched for sex, age, weight, height and type of surgery. Fifteen of the groups underwent abdominal surgery, mostly abdominal hysterectomy; the remaining 10 groups had a variety of orthopaedic procedures performed, mainly for the treatment of rheumatoid arthritis. The three patients in each group received either meptazinol 100 mg, pethidine 100 mg or pentazocine 60 mg i.m. for pain after operation; a placebo was not included for ethical reasons. The dose of meptazinol was based on earlier findings (Paymaster, 1976) while those of pethidine and pentazocine are in general clinical use. The drugs were presented in identical ampoules and prescribed in a double-blind, predetermined random order. Female patients known to be pregnant, drug-addicted patients and those suffering from active hepatic or renal disease were excluded. The patients gave informed consent to participation in the project.
In those patients who were to undergo abdominal surgery, a Vitalograph spirometer and a Wright Peak Flow Meter were used to determine the forced vital capacity (FVC), forced expiratory volume in one second (FEVJ and peak expiratory flow rate (PEFR) with the patient in the semi-recumbent position. The procedure for performing these tests was explained fully to the patients and familiarity with the apparatus was ensured at the visit before surgery. The maximum of at least three measurements was accepted as the correct estimate of FVC, FEV X and PEFR.
Premedication consisted of lorazepam 2 mg administered orally on the night before surgery; patients undergoing surgery in the afternoon received additional lorazepam 2 mg orally not later than 6 h before surgery was anticipated. Patients suffering from rheumatoid arthritis and who were taking cortisone or similar drugs were given an injection of hydrocortisone 100 mg i.m. 1 h before surgery. No other drugs were given in the period immediately before operation. The general anaesthetic technique consisted of the i.v. injection of a barbiturate, nitrous oxide and oxygen supplemented with halothane when necessary; a non-depolarizing muscle relaxant, artificial ventilation, atropine and neostigmine (to antagonize the neuromuscular block) were also used in patients undergoing abdominal surgery. I.v. fluids (dextrose, saline, blood, Hartmann's solution, dextran) were administered as required. No other drugs were used.
When the patients required pain relief in the period immediately after operation, they were interviewed by the author and asked to assess their pain as absent, very slight, slight, moderate, severe or very severe (subjective pain score). In addition, the investigator made an overall assessment of the patient's pain on an identical six-point scale (objective pain score). A relaxed or tense facial expression, presence or absence of body movements, the effect of deep breathing or coughing and general credibility of the patient were additional criteria used in the observer assessment (Steinhaus et al., 1964) . A note was made of the patient's state of consciousness (awake, drowsy or asleep). Another series of FVC, JFEV 1 and PEFR measurements was made in patients who had undergone abdominal surgery. An i.m. injection of one of the trial drugs was then given in a double-blind manner-neither the patient nor the observer was aware of its identity. Objective and subjective assessments of pain severity and level of consciousness were repeated at 30 min, 1 and 2 h after the injection. In those patients who had abdominal surgery the pulmonary function tests were performed 1 h after the injection. Careful attention was paid to securing the maximum co-operation of the patient (in a semi-recumbent position identical to that at the time of the visit before operation) during the performance of the lung function tests. A note was made of any side-effects and drugs required in their treatment. For further pain relief, i.m. injections of morphine 10 mg were administered in a single-blind manner-the patient did not know that the trial drug and morphine were different drugs.
Arterial pressure and heart rate were recorded at half-hourly intervals for 5 h after the injection of each of the three trial drugs.
The patients were interviewed the following day and questioned about side-effects and preference for the trial drug or morphine.
RESULTS
The characteristics of the three groups of patients are shown in table I. There were no significant differences between the groups.
The mean time of injection of the trial drug was 1.3 h after completion of the operation (range 0.1-3.5 h); there was no significant difference between the groups.
For the analysis of pain relief, the descriptive scores were assigned numerical values from 0 to 5, and a pain relief score was calculated as the pain score before treatment minus the pain score after treatment. Because of the ordinal nature of the pain scores, changes in pain severity have been analysed using non-parametric tests (Siegel, 1956 ). However, for convenience the data are expressed as means and standard errors in the tables and figures. Changes in respiratory function tests are expressed as the percentage improvement calculated from the following:
Percentage improvement = post-treatment-pretreatment preoperative-pretreatment xlOO
Subjective and observer pain assessments
The mean pain relief scores for all patients are presented in tables II and III and figures 1 and 2. There was a good correlation between the patient's (subjective) and the observer's assessments of pain relief, although the latter tended to be greater than the former. All three drugs produced significant analgesia which was maximal 30-60 min after injection and was still appreciable after 2h (P<0.01). There were no significant differences between the pain scores before treatment and the pain relief scores (subjective and observer) for the three analgesics at any time (Friedman two-way analysis of variance).
Because of differences in the type and severity of pain following abdominal and orthopaedic surgery, the data were subdivided with respect to the two types of operation. The mean pain relief scores are shown in figures 3, 4, 5 and 6 and tables II and III. There was no significant difference between the pain scores before treatment for the abdominal and orthopaedic groups. The only significant difference between the two groups in respect of pain relief with the three analgesics was that pain relief was significantly greater in the orthopaedic group with both meptazinol (subjective and observer) and pentazocine (observer) at 1 h (Mann-Whitney U test, P<0.01). There was a general trend for the degree of pain relief to be greater following orthopaedic surgery. The peak analgesic effect occurred 30 and 60 min following injection in the patients who had undergone abdominal and orthopaedic surgery respectively. However, within the two groups there were no significant differences in the degree of pain relief produced by meptazinol, pethidine and pentazocine (Friedman two-way analysis of variance). Thus the degree of pain relief produced by meptazinol following abdominal or orthopaedic surgery was not significantly different from that produced by pethidine and pentazocine. The actions of all three drugs appear to have a similar time course. However, there was a tendency for the peak analgesic effect of meptazinol to occur earlier and to decline more rapidly (see below).
Pulmonary function tests
Pulmonary function measurements were carried out only on those patients undergoing abdominal surgery. Measurements before operation and measurements immediately before and 1 h following the administration of the trial drug were available for the majority of the patients (table IV). After surgery there was a similar (approximately 40%) decrease in FVC, FEV X and PEFR in the three groups of patients about to receive meptazinol, pethidine or pentazocine.
One hour following the administration of any one of the three analgesics there was an improvement in pulmonary function tests. Following the administraton of meptazinol there was a statistically significant improvement in all three tests (FVC, FEV 1 and PEFR); after pethidine or pentazocine administration there was significant improvement in FEV 1 and PEFR and in FVC and PEFR respectively. The percentage improvement in respiratory variables tended to be greater following the administration of meptazinol. However, the differences between the three analgesics were not statistically significant (parametric analysis of variance).
Level of consciousness
Figure 7 shows the changes in the level of consciousness following the administration of the three analgesics. The three levels (awake, drowsy, asleep) were assigned the numerical values 1, 2 and 3 and the data were analysed in a manner similar to that for the pain scores. The degree of sedation following administration of pethidine or pentazocine was greater than that after meptazinol. However, the differences between the three drugs were not statistically significant.
Duration of action
Although no firm data were obtained for the duration of action of the three analgesics, an approximate estimation was made from the interval between the administration of the trial drug and the administration of subsequent doses of analgesic. The average times are shown in table V. There was a trend for the interval to increase in the order meptazinol, pethidine, pentazocine. However, the differences were not statistically significant (Friedman two-way analysis of variance, 0.1 >P> 0.05). Two patients in the pethidine group and four in the pentazocine group did not require further analgesics in the first 24 h after operation or required only oral analgesics. When these patients were excluded, the average times were 3.9, 5.0 and 5.1 h for meptazinol, pethidine and pentazocine respectively, and the differences between the three analgesics were less apparent.
Patient preference for trial drug or morphine
Two-thirds of the patients received an injection of morphine after the trial drug and were able to compare the effectiveness of the two treatments. shows the data for patient preference for morphine or the trial drug. There was no significant difference between the three trial drugs.
Side-effects and toxicity
Neither arterial pressure nor heart rate was affected significantly by the administration of meptazinol, pethidine or pentazocine.
The frequencies of side-effects for all patients were: pentazocine, 12%; meptazinol, 28%; pethidine, 40% (table VII). The frequencies of side-effects for the pentazocine, meptazinol and pethidine groups were 10, 20 and 30% respectively following orthopaedic surgery and 13, 33 and 47% respectively following abdominal surgery but the difference was not significant. There was no significant difference in the frequency of side-effects between the three analgesics (x 2 = 5.03, P = 0.1-0.05). Nausea and vomiting were the predominant side-effects; no patient required treatment for vomiting associated with the administration of any of the three trial drugs. Meptazinol 100 mg given i.m. produced significant pain relief in patients, following abdominal or orthopaedic surgery, comparable to that produced by pentazocine 60 mg and pethidine 100 mg. As one would expect, the degree of pain relief tended to be greater in patients who had undergone orthopaedic surgery. Patient-preference data for either the trial drug or morphine did not reveal any differences between the three trial drugs and between them and morphine. There was some evidence that the duration of action of meptazinol was shorter than that for pethidine or pentazocine but the difference was not statistically significant. Meptazinol produced less sedation than pethidine or pentazocine. It is possible that this lack of sedative effect may have contributed to a shorter duration of analgesia. Although the analgesic effect of meptazinol was similar to that of pethidine and pentazocine, it produced a greater improvement in pulmonary function. This may be because meptazinol depresses respiration less than pentazocine and pethidine, or it may be that the patients were not as sedated by it and were able to co-operate better with the performance of the pulmonary function tests. Whatever the reason, greater improvement in lung function may mean fewer pulmonary complications after operation with meptazinol. The relationship between pain relief scores and improvement in lung function tests seen in this study confirms their value as indices of pain relief as noted in previous investigations (Masson, 1962; Parkhouse and Holmes, 1963; Kolliker, 1972; Paymaster, 1976) .
The assessment of subjective responses, such as the effect of treatment on the intensity of pain, requires an accurate and sensitive method. The use of the simple descriptive pain scale has been criticized on the grounds that the relative size of differences between descriptive terms is unknown. However, this problem can be overcome by the use of non-parametric statistical tests, since in using these tests no assumptions need be made concerning the equality of the intervals between points on the scale of measurement (Siegel, 1956) .
There was no significant difference in the frequency of side-effects between the three analgesics. Although the frequency for all three drugs tended to be greater following abdominal than following orthopaedic surgery, the difference was not statistically significant.
The results of this investigation confirm an earlier observation (Paymaster, 1976 ) that meptazinol does not produce any cardiovascular depression in therapeutic doses. No significant changes in arterial pressure and heart rate were observed for a period of 5 h after its administration.
Goode and White (1971) noted a low dependence potential for meptazinol in rats. If its non-addictive properties are confirmed in man, meptazinol will be a useful addition to the range of non-addicting, opiateantagonist drugs with analgesic properties. 
SUMARIO
En una investigation de doble anonimato sobre la eficacia del combate de dolor posterior a cirujia abdominal u ortopedica, se encontro que metazinol 100 mg, un nuevo derivado de hexahidroazepina, resultaba equipotente a pentazocina 60 mg y petidina 100 mg, al suministrarlo intramuscularmente. La analgesia maxima se presentaba entre 30-60 min despues de recibida la inyeccion y continuaba presente al cabo de 2 h. Se calculo que la duration de los efectos de meptazinol era de 4 h. Meptazinol produjo menos sedation y una menor cantidad de pruebas de funcionamiemo pulmonar que lo hicieron petidina y pentazocina. Cuando se suministro meptazinol o morfina para mayor alivio de dolor a modo de anonimato simple, no se not6 preferencia de pane de los pacientes por una u otra de las drogas.
